罗宾的全面审查:分布,生物活性和药理学参数
1Department of Biology and Pharmacognosy, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, Mickiewicza 2a, 15-230 Białystok, Poland.
International journal of molecular sciences
|October 16, 2025
概括
罗宾是一种天然的黄醇,显示出治疗感染,炎症和代谢障碍的前景. 需要进一步的研究来探索其作为制药化合物的治疗潜力.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 罗宾是一种在药用植物中发现的多氧化黄醇,特别是Fabaceae家族.
- 它在传统医学中用于治疗各种疾病的历史悠久.
- 它的生物活动和治疗潜力是科学兴趣日益增长的领域.
研究的目的:
- 综合审查罗宾的自然发生,提取,表征和药理性质.
- 总结关于罗宾的生物活性和潜在的治疗应用的当前知识.
- 强调需要进一步研究其作为药物剂的有效性.
主要方法:
- 关于民族植物学数据,提取技术,光谱表征和药理学研究的文献综述.
- 对报告的生物活性进行分析,包括抗病毒,抗菌,抗氧化剂和酶抑制.
- 检查体内研究和分子相互作用的计算建模.
主要成果:
- 罗宾具有广泛的生物活性:抗病毒,抗菌,抗寄生虫,抗氧化剂,抗变异剂和酶抑制 (例如,HIV-1整合酶,乙胆酶).
- 它对癌症细胞系和潜在的肝脏保护和代谢调节功能表现出适度的抗增殖作用.
- 计算研究表明与CDK1等点的相互作用,支持其治疗潜力.
结论:
- 罗宾具有显著的多方面的治疗潜力,得到了各种生物活性和初步体内数据的支持.
- 它的抗氧化特性与氧化还原行为和金属化能力有关,尽管其水溶性差.
- 进一步的药理动力学和临床研究至关重要,以验证罗宾作为开发新型植物化学衍生药物的主要化合物.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.7K
10:44Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
10.2K
相关概念视频
01:10Pharmacokinetics: Overview
9.0K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.0K
01:17Bioavailability: Overview
355
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
355
01:13Bioavailability: Overview
4.1K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
4.1K
01:27Bioavailability Study Design: Absolute Versus Relative Bioavailability
293
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
293
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
228
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
228
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
202
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
202